[1]Schelde AB,Eliasen A,Olesen JB,et al.Real-world effectiveness and safety of pharmacological thromboprophylaxis in patients undergoing primary total hip and knee arthroplasty:A narrative review[J].J Orthop,2020,12(19):166-173.
[2]Taneja A,El-Bakoury A,Khong H,et al.Association between allogeneic blood transfusion and wound infection after total hip or knee arthroplasty:a retrospective case-control study[J].J Bone Joint In,2019,4(2):99-105.
[3]中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.
[4]围手术期高血压管理专家共识[J].临床麻醉学杂志,2016,32(3):295-297.
[5]Martin-Ventura JL,Martinez-Lopez D,Roldan-Montero R,et al.Role of complement system in pathological remodeling of the vascular wall[J].Mol Immunol,2019,10(114):207-215.
[6]刘江锋.氨甲环酸纱布在无止血带下对膝关节置换失血量的影响[J].实用骨科杂志,2019,25(8):748-752.
[7]温焕,徐菊玲,姚行,等.全膝关节置换术后隐性失血的防治进展[J].中西医结合护理(中英文),2019,5(7):227-230.
[8]Park JH,Rasouli MR,Mortazavi SM,et al.Predictors of perioperative blood loss in total joint arthroplasty[J].J Bone Joint Surg(Am),2013,95(19):1777-1783.
[9]韩宁,姚建华,黄炎,等.高血压对全膝关节置换术围手术期出血的影响[J].中国矫形外科杂志,2016,24(7):603-607.
[10]吴松,王梓力,何榕真,等.性别对人工全膝关节置换术后临床疗效的影响[J].中国现代医学杂志,2014,24(18):55-58.
[11]李征,曹光磊,沈惠良.全膝关节置换术的隐性失血及影响因素分析[J].中华创伤杂志,2010(9):831-834.
[12]陈勇辉,彭冲,郑水淋,等.不同高血压分级患者治疗急性牙髓炎过程中的生命体征变化和影响因素分析[J].世界最新医学信息文摘,2019,19(71):12-13.
[13]Butler J,Kalogeropoulos AP,Georgiopoulou VV,et al.Systolic blood pressure and incident heart failure in the elderly.The cardiovascular health study and the health,ageing and body composition study[J].Heart,2011,97(16):1304-1311.
[14]刘旭东,张先龙,曾炳芳,等.全髋关节置换术后的隐性失血分析[J].中国矫形外科杂志,2011,19(12):995-997.
[15]Li JD,An WS,Xu Y,et al.Mechanism of vasoactive peptide intermedin in vascular collagen remodeling during angiotensin Ⅱ-induced hypertention[J].Eur Rev Med Pharmacol Sci,2018,22(17):5652-5658.